|
Patrick J. Zenner has served as a director of the Company since July 2001. Currently he is serving as interim Chief Executive Officer for CuraGen Corporation a genomics-based biopharmaceutical company. From 1969 until January 2001 Mr. Zenner held a series of executive managerial positions with Hoffmann La-Roche Inc. North America the prescription drug unit of the Roche Group a leading research-based health care enterprise. He retired as President and Chief Executive Officer in January 2001. Mr. Zenner has been a board member of numerous associations including the Pharmaceutical Research and Manufacturers Association the Health Care Institute of New Jersey the American Foundation for Pharmaceutical Education the American Society of Hospital Pharmacists Foundation the Health Care Leadership Council and the Biotechnology Industry Organization. He is also a director of Arqule Inc. Curagen Corporation Dendrite International Exact Sciences First Horizon Pharmaceutical Corporation Praecis Pharmaceuticals XOMA Ltd. and West Pharmaceutical Services. Mr. Zenner holds a B.S.B.A. from Creighton University and a M.B.A. from Fairleigh Dickinson University. He serves on the Board of Trustees for both universities. | 